Benefits Think Orphan drugs represent the worst and best of our healthcare system
The outrageous prices for exclusive medications are crippling our health plans and terrorizing families in pain.
The outrageous prices for exclusive medications are crippling our health plans and terrorizing families in pain.
The outrageous prices for exclusive medications are crippling our health plans and terrorizing families in pain.
The health insurer said it plans to sell its Medicare prescription drug business in a key step toward completing its $67.5 billion merger.
While the DOJ’s antitrust division says the merger doesn’t eliminate competition, industry experts are doubtful the deal will bring down costs or improve quality.
While the DOJ’s antitrust division says the merger doesn’t eliminate competition, industry experts are doubtful the deal will bring down costs or improve quality.
The deal is seen closing by the end of the year.
Management must realize that their workplace is not spared by the national epidemic of painkiller abuse. Here are steps to reduce their employees’ risk and loss of productivity.
Management must realize that their workplace is not spared by the national epidemic of painkiller abuse. Here are steps to reduce their employees’ risk and loss of productivity.
A system without rebates would require significant fundamental change to the foundational economics of the drug ecosystem.
A partnership strategy would make sense out of the gate for the online retailer, says UpWell Health CEO Alison Wistner.
A system without rebates would require significant fundamental change to the foundational economics of the drug ecosystem.
Prescription drugs for foreign countries cost a fraction compared to U.S. pricing. Of course they are more attractive but roadblocks remain.
Pharmacy benefit manager rebates and third-party revenues are killing employers’ prescription drug plans. Here’s what companies should do about it.
The online retail giant’s purchase of the drug delivery service could mean the end of pharmacy benefit managers and a major wake up call for benefit brokers, says Shandon Fowler.
Pharmacy benefit manager rebates and third-party revenues are killing employer’s prescription drug plans. What are the best strategies to adopt?
The online retail giant’s purchase of the drug delivery service could mean the end of pharmacy benefit managers and a major wake up call for benefit brokers, says Shandon Fowler.
The FDA issued draft guidelines Tuesday outlining possible steps patients can take to get prescription medications without seeing a doctor.
The online retail giant’s purchase of the e-pharmacy may deliver convenience but who will monitor customers for side effects and wrong dosages?
In the first 10 days of July, at least ten drugmakers and biotechnology companies have raised prices on at least 20 brand-name medicines.
With employers and employees going directly to the source for their specialty drug needs, pharmacy benefit managers and brokers will need to adapt quickly to a new healthcare landscape.